191 related articles for article (PubMed ID: 15472121)
41. Secreted APE1/Ref-1 inhibits TNF-α-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor.
Park MS; Choi S; Lee YR; Joo HK; Kang G; Kim CS; Kim SJ; Lee SD; Jeon BH
Sci Rep; 2016 Mar; 6():23015. PubMed ID: 26964514
[TBL] [Abstract][Full Text] [Related]
42. Identification of plasma APE1/Ref-1 in lipopolysaccharide-induced endotoxemic rats: implication of serological biomarker for an endotoxemia.
Park MS; Lee YR; Choi S; Joo HK; Cho EJ; Kim CS; Park JB; Jo EK; Jeon BH
Biochem Biophys Res Commun; 2013 Jun; 435(4):621-6. PubMed ID: 23685156
[TBL] [Abstract][Full Text] [Related]
43. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses.
Akhter N; Takeda Y; Nara H; Araki A; Ishii N; Asao N; Asao H
J Biol Chem; 2016 Nov; 291(45):23672-23680. PubMed ID: 27637330
[TBL] [Abstract][Full Text] [Related]
44. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Kaur G; Cholia RP; Mantha AK; Kumar R
J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
[TBL] [Abstract][Full Text] [Related]
45. Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release.
Fulton D; Babbitt R; Zoellner S; Fontana J; Acevedo L; McCabe TJ; Iwakiri Y; Sessa WC
J Biol Chem; 2004 Jul; 279(29):30349-57. PubMed ID: 15136572
[TBL] [Abstract][Full Text] [Related]
46. Apurinic/apyrimidinic endonuclease 1 inhibits protein kinase C-mediated p66shc phosphorylation and vasoconstriction.
Lee SK; Chung JI; Park MS; Joo HK; Lee EJ; Cho EJ; Park JB; Ryoo S; Irani K; Jeon BH
Cardiovasc Res; 2011 Aug; 91(3):502-9. PubMed ID: 21467074
[TBL] [Abstract][Full Text] [Related]
47. Apurinic/apyrimidinic endonucelase 1 maintains adhesion of endothelial progenitor cells and reduces neointima formation.
Yamauchi A; Kawabe J; Kabara M; Matsuki M; Asanome A; Aonuma T; Ohta H; Takehara N; Kitagawa T; Hasebe N
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(8):H1158-67. PubMed ID: 23934858
[TBL] [Abstract][Full Text] [Related]
48. Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response.
Ray S; Lee C; Hou T; Bhakat KK; Brasier AR
Mol Endocrinol; 2010 Feb; 24(2):391-401. PubMed ID: 20032196
[TBL] [Abstract][Full Text] [Related]
49. Regulation of arterial blood pressure by Akt1-dependent vascular relaxation.
Ha JM; Kim YW; Lee DH; Yun SJ; Kim EK; Hye Jin I; Kim JH; Kim CD; Shin HK; Bae SS
J Mol Med (Berl); 2011 Dec; 89(12):1253-60. PubMed ID: 21842346
[TBL] [Abstract][Full Text] [Related]
50. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.
Curtis CD; Thorngren DL; Ziegler YS; Sarkeshik A; Yates JR; Nardulli AM
Mol Endocrinol; 2009 Sep; 23(9):1346-59. PubMed ID: 19460860
[TBL] [Abstract][Full Text] [Related]
51. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase.
Hafezi-Moghadam A; Simoncini T; Yang Z; Limbourg FP; Plumier JC; Rebsamen MC; Hsieh CM; Chui DS; Thomas KL; Prorock AJ; Laubach VE; Moskowitz MA; French BA; Ley K; Liao JK
Nat Med; 2002 May; 8(5):473-9. PubMed ID: 11984591
[TBL] [Abstract][Full Text] [Related]
52. Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt-/- ).
Kubis N; Richer C; Domergue V; Giudicelli JF; Lévy BI
J Hypertens; 2002 Aug; 20(8):1581-7. PubMed ID: 12172320
[TBL] [Abstract][Full Text] [Related]
53. Cytoplasmic localization and redox cysteine residue of APE1/Ref-1 are associated with its anti-inflammatory activity in cultured endothelial cells.
Park MS; Kim CS; Joo HK; Lee YR; Kang G; Kim SJ; Choi S; Lee SD; Park JB; Jeon BH
Mol Cells; 2013 Nov; 36(5):439-45. PubMed ID: 24213673
[TBL] [Abstract][Full Text] [Related]
54. A dual regulatory role of apurinic/apyrimidinic endonuclease 1/redox factor-1 in HMGB1-induced inflammatory responses.
Yuk JM; Yang CS; Shin DM; Kim KK; Lee SK; Song YJ; Lee HM; Cho CH; Jeon BH; Jo EK
Antioxid Redox Signal; 2009 Mar; 11(3):575-88. PubMed ID: 18715145
[TBL] [Abstract][Full Text] [Related]
55. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells.
Simoncini T; Rabkin E; Liao JK
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):198-203. PubMed ID: 12588759
[TBL] [Abstract][Full Text] [Related]
56. Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B.
Hartell NA; Archer HE; Bailey CJ
Biochem Pharmacol; 2005 Mar; 69(5):781-90. PubMed ID: 15710355
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
Jiang A; Gao H; Kelley MR; Qiao X
Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
[TBL] [Abstract][Full Text] [Related]
58. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
[TBL] [Abstract][Full Text] [Related]
59. APE1/Ref-1: versatility in progress.
Jeon BH; Irani K
Antioxid Redox Signal; 2009 Mar; 11(3):571-4. PubMed ID: 18715142
[TBL] [Abstract][Full Text] [Related]
60. Altered AP-1/Ref-1 redox pathway and reduced proliferative response in iNOS-deficient vascular smooth muscle cells.
Chyu KY; Dimayuga PC; Zhao X; Nilsson J; Shah PK; Cercek B
Vasc Med; 2004 May; 9(3):177-83. PubMed ID: 15675181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
